Hydrocortisone | CAS:50-23-7
            
            Hydrocortisone
            - 名称:氢化可的松 | Hydrocortisone
 - CAS号:50-23-7
 - 别名:Cortisol; 11-beta,17-alpha,21-trihydroxypregn-4-ene-3,20-dione; Hydrocortisone Base
 - 分子式:C21H30O5
 - 分子量:362.46
 - EINESC号:200-020-1
 
产品描述
物理化学性质
| 熔点 | 213-220 ºC | 
|---|---|
| 比旋光度 | 166 º (c=1, C2H5OH 25 º | 
安全数据
| 危险品标志 | Xn | 
|---|---|
| 危险类别码 | R62;R63 | 
| 安全说明书 | S36/37;S45 | 
产品合成路线
                | 名称 | CAS号 | 
|---|
更多
            文章
                同行评议文献
                
                                        Cyclophosphamide and related anticancer drugsBaumann F and Preiss R Journal of Chromatography. B, Biomedical Sciences and Applications, 764(1-2), 173-192 (2001)
                                        Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells.Yuxuan Miao et al.Cell, 177(5), 1172-1186 (2019-04-30)
                                        Reciprocal Interaction between Vascular Filopodia and Neural Stem Cells Shapes Neurogenesis in the Ventral Telencephalon.Barbara Di Marco et al.Cell reports, 33(2), 108256-108256 (2020-10-15)
                                        Evaluation of anti-dengue activity of Carica papaya aqueous leaf extract and its role in platelet augmentation.Navita Sharma et al.Archives of virology, 164(4), 1095-1110 (2019-02-23)
                                        Assay of cyclophosphamideBoughton OD, et al. Journal of Pharmaceutical Sciences, 61(1), 97-100 (1972)
                                        High-performance thin-layer chromatography with a derivatization procedure, a suitable method for the identification and the quantitation of busulfan in various pharmaceutical productsBouligand J, et al. Journal of Pharmaceutical and Biomedical Analysis, 34(3), 525-530 (2004)
                                    
            备注
                
            Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
| 名称 | CAS号 | 
|---|
        
相关产品
相关资讯
问
    热门标签
    询 单
请 填 写 相 关 信 息
- 请填写产品名称!
 - CAS号
 - 请正确填写公司名称!
 - 请正确填写联系人!
 - 请正确填写联系电话!
 - 请正确填写联系邮箱!
 - 请描述您的问题!